Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About ANTA Interactive Breakdown Better Bets vs. ANTA Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Antalpha Platform (ANTA)

Market Price (10/31/2025): $11.4 | Market Cap: $246.1 Mil
Sector: Financials | Industry: Consumer Finance

Antalpha Platform (ANTA)

Market Price (10/31/2025): $11.4
Market Cap: $246.1 Mil
Sector: Financials
Industry: Consumer Finance

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0   Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 268%
1   Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 76x, P/EPrice/Earnings or Price/(Net Income) is 63x
2   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.0%
0 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 268%
1 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 76x, P/EPrice/Earnings or Price/(Net Income) is 63x
2 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.0%

Market Valuation & Key Metrics

ANTAS&P 500
REVENUE GROWTHGOOD
Rev LTM ($ Bil)0.1
Rev Chg Q49.0%6.4%
Rev Chg LTM�5.4%
PROFITABILITYPOOR
Op Inc LTM ($ Bil)0.0
CFO LTM ($ Bil)�
Net Inc LTM ($ Bil)0.0
Op Mgn LTM6.2%18.7%
Net Inc Mgn7.4%12.8%
VALUATIONVERY HIGH
P/S4.63.2
P/E62.823.6

ANTA Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
null

null
null

null
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
ANTA Return------0%
Peers Return2%13%-22%33%-13%-12%-10%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
ANTA Win Rate-----50% 
Peers Win Rate23%34%22%27%27%36% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
ANTA Max Drawdown------ 
Peers Max Drawdown-18%-4%-26%-18%-32%-34% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: PRAA, PHH, SNTG, SUIG, AXP.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

ANTA has limited trading history. Below is the Financials sector ETF (XLF) in its place.

Unique KeyEventXLFS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-26.9%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven36.7%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven525 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-43.3%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven76.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven295 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-26.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven35.2%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven338 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-83.7%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven515.2%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven4470 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -26.9% during the 2022 Inflation Shock from a high on 1/12/2022. A -26.9% loss requires a 36.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Antalpha Platform (ANTA)

Better Bets than Antalpha Platform (ANTA)

 ANTABetter Performance than ANTA
MetricValueIndustry (Consumer Finance)
Op Mgn LTM6.2%FCFS (14.5%), CACC (23.5%), ENVA (12.5%), SEZL (37.0%), PRG (16.5%)
Total Yield1.6%AXP (4.2%), COF (6.9%), SOFI (1.7%), SYF (14.8%), ALLY (5.9%)
 ANTABetter Performance than ANTA
MetricValueAll Other Sectors
Op Mgn LTM6.2%NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AMZN (11.4%)
Total Yield1.6%NVDA (1.8%), AAPL (2.8%), MSFT (3.3%), GOOGL (3.9%), AMZN (3.0%)
 Best Bets In Financials Sector
 ANTADBRG OTF MTG NMIH CACC ENVA FNF ACGL APAM FI
What You Pay           
P/E63.339.713.28.47.512.310.213.98.610.510.6
P/EBIT75.864.79.06.45.59.97.88.97.66.15.8
What You Get           
Rev Chg Q49.0%-102.4%1,228.5%-0.7%7.2%8.3%16.3%16.8%22.4%4.4%8.0%
Rev Chg LTM�-84.8%89.0%2.2%10.0%12.5%21.1%7.4%23.5%10.0%6.7%
Rev Chg 3Y Avg�125.8%221.9%1.2%10.1%6.9%23.5%-0.7%29.8%0.2%7.5%
FCF/Rev 3Y Avg�101.2%76.2%62.2%58.8%57.1%54.7%50.8%38.4%29.0%20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

Trade Ideas

Select past ideas related to ANTA. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Antalpha Platform

Financials

ANTAPRAAPHHSNTGSUIGAXPMedian
NameAntalpha.PRA Park Ha .Sentage Sui American. 
Mkt Price11.5013.730.392.542.70358.887.10
Mkt Cap0.20.5---248.30.5
Rev LTM531,142--470,428598
Op Inc LTM3207----105
FCF LTM--62--618,9446
FCF 3Y Avg--69---016,904-0
CFO LTM--58--621,1396
CFO 3Y Avg--65---018,801-0

Growth & Margins

ANTAPRAAPHHSNTGSUIGAXPMedian
NameAntalpha.PRA Park Ha .Sentage Sui American. 
Rev Chg LTM-15.8%--76.6%9.1%15.8%
Rev Chg 3Y Avg-5.2%--0.3%11.6%5.2%
Rev Chg Q49.0%1.4%--250.4%10.8%29.9%
QoQ Delta Rev Chg LTM11.8%0.4%--49.0%2.6%7.2%
Op Mgn LTM6.2%18.1%----12.1%
Op Mgn 3Y Avg-10.4%----10.4%
QoQ Delta Op Mgn LTM-4.1%-0.8%-----2.4%
CFO/Rev LTM--5.0%--158.3%30.0%30.0%
CFO/Rev 3Y Avg--6.4%---15.0%29.2%-6.4%
FCF/Rev LTM--5.4%--158.3%26.9%26.9%
FCF/Rev 3Y Avg--6.9%---15.0%26.3%-6.9%

Valuation

ANTAPRAAPHHSNTGSUIGAXPMedian
NameAntalpha.PRA Park Ha .Sentage Sui American. 
Mkt Cap0.20.5---248.30.5
P/S4.70.5---3.53.5
P/EBIT75.82.3----39.0
P/E63.35.9---23.623.6
P/CFO--9.4---11.71.2
Total Yield1.6%17.0%---4.2%4.2%
Dividend Yield0.0%0.0%---0.0%0.0%
FCF Yield 3Y Avg--9.7%---10.7%0.5%
D/E2.86.7---0.22.8
Net D/E2.76.4---0.02.7

Returns

ANTAPRAAPHHSNTGSUIGAXPMedian
NameAntalpha.PRA Park Ha .Sentage Sui American. 
1M Rtn-5.7%-11.1%-19.5%-18.6%-30.1%8.3%-14.8%
3M Rtn-2.1%-9.7%-46.6%49.4%-20.2%-2.1%
6M Rtn--25.3%-97.3%55.9%-34.3%4.5%
12M Rtn--31.3%-96.5%17.6%-32.4%-6.9%
3Y Rtn--59.0%-96.5%19.2%-150.9%-19.9%
1M Excs Rtn-4.2%-11.4%-21.2%-21.5%-36.8%7.8%-16.3%
3M Excs Rtn-10.8%-18.2%-50.9%39.2%-12.9%-10.8%
6M Excs Rtn--47.1%-119.0%34.1%-12.6%-17.2%
12M Excs Rtn--45.2%-113.7%-4.5%-16.5%-24.8%
3Y Excs Rtn--133.8%-173.3%-58.6%-76.6%-96.2%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q4
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/2023
Filing Date8/13/20256/17/20255/15/20252/5/20258/13/20256/17/20255/15/2025
Key Financials Quarterly       
Total Revenue1710131311146
Net Income102111-2
EPS0.030.010.070.060.050.06-0.07
Key Financials TTM       
Total Revenue TTM53475144---
Net Income TTM4462---
Growth Rates Quarterly       
Total Revenue Growth49.0%-29.1%132.8%----
Net Income Growth-41.3%-80.9%208.0%----
Margins Quarterly       
Net Income Margin4.0%2.9%12.5%10.0%10.1%10.7%-26.8%
Cash & Debt       
Total Cash352630--0
Total Debt70059141051100346
Net Debt / (Cash)666589404482--346
Cash Flows Quarterly       
FCF from Operations--1----3
Cash Flows TTM       
FCF from Operations TTM-------
Returns to Shareholders Quarterly       
Dividends0000000
Share Repurchases-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly       
ROIC-0.2%0.0%1.5%1.2%---1.3%
Return on Invested Capital (ROIC) TTM       
ROIC TTM0.4%0.7%1.1%0.4%---

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity11,355
Short Interest: % Change Since 930202524.6%
Average Daily Volume33,011
Days-to-Cover Short Interest1
Basic Shares Quantity21,585,385
Short % of Basic Shares0.1%

Returns Analyses

SEC Filings

Expand for More

Report DateFiling DateFiling
630202581320256-K 6/30/2025
331202561720256-K 3/31/2025
123120245152025424B4 12/31/2024
93020242052025DRS/A 9/30/2024

Insider Activity

Expand for More

 

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.